SPI-77, liposomal: Clinical Trials

4 trials of SPI-77, liposomal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 2
Phase 31Completed 1

Follow SPI-77, liposomal: new trials by email Literature Review of SPI-77, liposomal trials Research Report on SPI-77, liposomal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
Cisplatin, liposomal, Verteporfin, Device for Intrapleural Visudyne-mediated Low-Dose Photodynamic Therapy with integrated in situ light dosimetry - Pleural Effusion, Malignant
Phase 1TerminatedCentre Hospitalier Universitaire Vaudois12016-01-012019-03-20
Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung
Cisplatin liposomal - Osteosarcoma Metastatic
Phase 1 / Phase 2CompletedInsmed Incorporated192005-01-122017-08-01
Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
fluorouracil, gemcitabine hydrochloride, liposomal cisplatin - Pancreatic Cancer
Phase 3CompletedFederation Francophone de Cancerologie Digestive1902000-03-012016-05-30
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
cisplatin liposomal - Ovarian Cancer
Phase 2CompletedNYU Langone Health1999-02-012011-03-28

Conditions studied

Carcinoma, Ovarian Epithelial (1)  ·  Neoplasm Metastasis (1)  ·  Osteosarcoma (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Pleural Effusion, Malignant (1)  ·  Recurrence (1)

Sponsors

Centre Hospitalier Universitaire Vaudois (1)  ·  Federation Francophone de Cancerologie Digestive (1)  ·  Insmed Incorporated (1)  ·  NYU Langone Health (1)

Countries

United States (2)  ·  Switzerland (1)

Top investigators

Francoise Mornex, MD, PhD (1)  ·  Hans-Beat Ris, MD, Prof. (1)  ·  Howard S. Hochster, MD (1)  ·  Renu Gupta, MD (1)  ·  Richard Gorlick, MD (1)

Results publications

PMID 18467316, PMID 23255417

NIH funding

P30CA016087 (1)